ArticleScientific reports2022

Author Correction: Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma.

Nancy S Younis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.